Today, Ambu announces its preliminary financial 2022/23 results. For the financial year 2022/23, EBIT before special items totalled DKK 302m, with an EBIT margin before special items of 6.3% (previous ...

Ambu raises its expectations for EBIT margin before special items to 5 - 6% (previously 3 - 5%) for the full-year 2022/23, based on its preliminary Q3 results. For Q3 2022/23, EBIT before special ...

Ambu A/S Class B (($DK:AMBU.B)) has held its Q4 earnings call. Read on for the main highlights of the call. Ambu A/S Class B’s recent earnings call highlighted a ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Today, Ambu announces its financial guidance for the fiscal year 2023/24. Also, today, Ambu will publish its Q4 and full-year earnings release along with its Annual Report, including the company’s ...

Ambu expands its addressable market by supporting FEES procedures. COLUMBIA, Md.--(BUSINESS WIRE)--Ambu continues to advance the market for single-use endoscopy by addressing Fibreoptic Endoscopic ...

COLUMBIA, Md.--(BUSINESS WIRE)--Ambu Inc., the world leader in single-use endoscopes, announced today that it has been awarded a national single-use endoscopy contract in the category of Single-Use ...

A pioneering medical device company based in Columbia, Ambu Inc. has become the largest manufacturer of single-use endoscopes – instruments inserted into a person to view internal parts – in the world ...

The chief executive of Ambu A/S added to his stake in the Danish medtech company this week and once again the market rewarded him with a bump in the stock price. Juan Jose Gonzalez snapped up 137,600 ...